Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Leucomax/Mielogen/SCH34300
Also marketed in the EU under the name(s): Leucomax, Mielogen, SCH 39300
Active substance: molgramostim
Indication: Leucomax is indicated to reduce the risk of infection due toneutropenia in patients treated with cytotoxic chemotherapy for malignant diseases
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/06/2000 Referral EMEA/H/A/283 (2000)1485 of 27/06/2000